NCT06631066View on ClinicalTrials.gov

Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

October 10, 2023

Study Completion Date

July 15, 2024

Conditions
Breast Cancer Female
Interventions
RADIATION

neoadjuvant chemoradiation

Neoadjuvant chemoradiation will be prescribed as: 4 cycles of Adriamycin and Cyclophosphamide followed by radiotherapy concurrently with taxanes/ taxanes and carboplatin. followed by surgery as indicated.

Trial Locations (1)

Unknown

National Cancer Institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT06631066 - Effect of Neoadjuvant Chemoradiation on Pathologic Complete Response Rates in Locally Advanced Breast Cancer Patients | Biotech Hunter | Biotech Hunter